Clinical Trial

Functional MRI for Monitoring Progression and Assessing Trends in ILD

Study acronym: IMPACT-ILD
Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of this study is to investigate the utility of functional MRI to differentiate, characterize, and monitor subgroups of ILD. This can be broken down into three specific objectives: Determine if ILD features observed on high-resolution computed tomography (HRCT), such as ground glass opacities (GGO), are functionally different. Analyse MRI metrics within each subgroup to determine whether these metrics distinguish different ILDs. Assess MRI metrics longitudinally to see if these parameters change with disease progression, stability, or reversibility.
Trial Details
NCT Number NCT07300696
Lead Sponsor University Hospital Heidelberg
Collaborators: German Center for Lung Research, Thoraxklinik-Heidelberg gGmbH, University Hospital Schleswig-Holstein
Conditions Interstitial Lung Diseases (ILD)
Enrollment 200 participants
Start Date 2025-11-20
Primary Completion 2027-02 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-24